The study compared the effectiveness and safety of remimazolam besylate to ciprofol in elderly patients during painless gastrointestinal endoscopy.
Patients were divided into a control group (ciprofol) and an observation group (remimazolam besylate) to analyze various factors like anesthesia onset time, recovery time, hemodynamics, and cognitive function.
Results indicated that remimazolam besylate provided quicker anesthesia and recovery, more effective analgesia, better hemodynamic stability, and less cognitive impairment, with no significant difference in adverse reactions between the two groups.
Overall, remimazolam besylate was found to be a superior choice for elderly patients in this procedure.